Niagen Bioscience (NAGE) Shares Outstanding (2011 - 2026)

Niagen Bioscience (NAGE) has reported Shares Outstanding (Entity) for 16 consecutive years, with $79.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 1.31% year-over-year to $79.5 million; the TTM figure through Mar 2026 stood at $79.5 million (up 1.31% YoY), while the FY2025 annual figure was $79.7 million, up 3.08% from the prior year.
• Shares Outstanding (Entity) held at $79.5 million in Q1 2026 per NAGE's latest filing, from $79.7 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $79.7 million in Q4 2025 and bottomed at $68.1 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $75.3 million across 5 years, with a median of $75.2 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) advanced 0.11% — and 2023, when it climbed 9.89%.
• Niagen Bioscience's Shares Outstanding (Entity) stood at $74.6 million in 2022, then rose by 0.56% to $75.0 million in 2023, then advanced by 3.13% to $77.3 million in 2024, then advanced by 3.08% to $79.7 million in 2025, then fell by 0.32% to $79.5 million in 2026.
• Business Quant data shows NAGE's Shares Outstanding (Entity) at $79.5 million in Q1 2026, $79.7 million in Q4 2025, and $79.6 million in Q3 2025.